Strs Ohio Neurocrine Biosciences Inc Transaction History

Strs Ohio

$26.2 Billion
Q3 2025

A detailed history of Strs Ohio transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Strs Ohio holds 2,316 shares of NBIX stock, worth $335,495. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,316

Previous 2,315 0.04%

Holding current value

$335,495

Previous $290,000 12.07%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 30, 2025	BUY	$123.98 - $146.67 $123 - $146	1 Added 0.04%	2,316 $325,000
Q2 2025 Aug 04, 2025	BUY	$87.54 - $128.18 $202,655 - $296,736	2,315 New	2,315 $290,000
Q3 2024 Nov 01, 2024	SELL	$114.58 - $153.15 $514,807 - $688,102	-4,493 Reduced 21.33%	16,569 $1.91 Million
Q2 2024 Aug 05, 2024	BUY	$130.86 - $143.19 $634,409 - $694,185	4,848 Added 29.9%	21,062 $2.9 Million
Q1 2024 May 13, 2024	BUY	$130.4 - $143.74 $176,952 - $195,055	1,357 Added 9.13%	16,214 $2.24 Million

Q4 2023 Jan 30, 2024	BUY	$106.07 - $132.76 $1.58 Million - $1.97 Million	14,857 New	14,857 $1.96 Million
Q2 2023 Jul 31, 2023	SELL	$89.53 - $104.87 $163,660 - $191,702	-1,828 Reduced 9.54%	17,341 $1.64 Million
Q1 2023 Aug 02, 2023	BUY	$94.11 - $123.02 $172,033 - $224,880	1,828 Added 10.54%	19,169 $1.94 Million
Q1 2023 Apr 27, 2023	BUY	$94.11 - $123.02 $286,282 - $374,226	3,042 Added 18.86%	19,169 $1.94 Million
Q4 2022 Jan 26, 2023	BUY	$106.72 - $127.06 $325,175 - $387,151	3,047 Added 23.3%	16,127 $1.93 Million
Q3 2022 Oct 27, 2022	BUY	$92.03 - $107.81 $19,510 - $22,855	212 Added 1.65%	13,080 $1.39 Million
Q2 2022 Jul 25, 2022	BUY	$75.79 - $100.07 $900,233 - $1.19 Million	11,878 Added 1199.8%	12,868 $1.25 Million
Q2 2021 Jul 26, 2021	SELL	$89.43 - $102.27 $735,472 - $841,068	-8,224 Reduced 89.26%	990 $96,000
Q1 2021 Apr 23, 2021	SELL	$87.57 - $119.4 $1.17 Million - $1.59 Million	-13,343 Reduced 59.15%	9,214 $896,000
Q4 2020 Jan 25, 2021	SELL	$86.91 - $108.33 $74,221 - $92,513	-854 Reduced 3.65%	22,557 $2.16 Million
Q3 2020 Dec 14, 2020	SELL	$96.16 - $135.15 $115,968 - $162,990	-1,206 Reduced 4.9%	23,411 $2.25 Million
Q2 2020 Jul 23, 2020	BUY	$85.09 - $130.36 $1.45 Million - $2.22 Million	17,038 Added 224.81%	24,617 $3 Million
Q1 2020 Apr 23, 2020	BUY	$75.11 - $113.76 $127,236 - $192,709	1,694 Added 28.79%	7,579 $655,000
Q4 2019 Jan 24, 2020	BUY	$86.8 - $118.57 $510,818 - $697,784	5,885 New	5,885 $632,000
Q3 2019 Oct 21, 2019	SELL	$83.82 - $101.5 $0 - $0	0 Closed	0 $0
Q2 2019 Jul 25, 2019	SELL	$72.24 - $91.27 $130,609 - $165,016	-1,808 Closed	0 $0
Q1 2019 Apr 19, 2019	SELL	$69.31 - $91.53 $59,537 - $78,624	-859 Reduced 32.21%	1,808 $159,000
Q4 2018 Jan 23, 2019	BUY	$68.32 - $124.36 $44,134 - $80,336	646 Added 31.96%	2,667 $190,000
Q3 2018 Oct 19, 2018	SELL	$98.88 - $125.85 $16,315 - $20,765	-165 Reduced 7.55%	2,021 $248,000
Q2 2018 Aug 06, 2018	BUY	$75.3 - $105.99 $164,605 - $231,694	2,186 New	2,186 $214,000

Others Institutions Holding NBIX

# of Institutions

724

Shares Held

102M

Call Options Held

230K

Put Options Held

477K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $13.9B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Strs Ohio with notifications on news.

Account